USE OF INSULIN DETEMIR AND INSULIN GLARGINE DURING PREGNANCY: ARE THE DATA CONVINCING? RESPONSE

被引：0
|
作者：
Grunberger, George
Handelsman, Yehuda
Mechanick, Jeffrey I.
Blonde, Lawrence
机构：
来源：
ENDOCRINE PRACTICE | 2011年 / 17卷 / 05期
关键词：
AMERICAN ASSOCIATION; DIABETES-MELLITUS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：830 / 831
页数：2
相关论文
共 50 条
  • [41] Use of insulin glargine during pregnancy: A review (vol 15, pg 379, 2021)
    Jethwani, Pratap
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (05)
  • [42] Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy
    Lepercq, Jacques
    Lin, Jay
    Hall, Gillian C.
    Wang, Edward
    Dain, Marie-Paule
    Riddle, Matthew C.
    Home, Philip D.
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2012, 2012
  • [43] Insulin glargine 300 U/mL safety data in pregnancy
    Westerbacka, Jukka
    Duverne, Marielle
    Grulovic, Natasa
    Thummisetti, Sreenivas
    Doder, Zoran
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2322 - 2325
  • [44] Assessing differences in utilization and costs between insulin detemir (Levemir®) and insulin glargine (Lantus®) users
    Borah, B.
    Alemayehu, B.
    Henk, H. J.
    Forma, F. M.
    VALUE IN HEALTH, 2008, 11 (03) : A228 - A228
  • [45] Comment and Reply on:: Relative efficacy effectiveness and relative costs of treatment with insulin glargine and insulin detemir
    Freemantle, Nick
    Stella, Peter
    Munro, Vicki
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (08) : 1761 - 1762
  • [46] Effects of Insulin Detemir Versus Insulin Glargine on Intake and Satiety Factors in Type 1 Diabetes
    Garimella, Madhavi
    Mitchell, Stephen
    Burge, Mark R.
    DIABETES, 2011, 60 : A687 - A687
  • [47] ECONOMIC ANALYSIS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Acevedo, G. A. R.
    VALUE IN HEALTH, 2009, 12 (07) : A408 - A409
  • [48] An audit of the safety of insulin glargine in pregnancy
    Varughese, G. I.
    Tahrani, A. A.
    Wilkins, J.
    Taylor, S.
    Hanna, F. W.
    DIABETIC MEDICINE, 2007, 24 : 113 - 113
  • [49] DRUG-USE PATTERNS OF INITIALLY PRESCRIBED INSULIN DETEMIR AND INSULIN GLARGINE IN THE NETHERLANDS; A COMPARATIVE ANALYSIS USING PHARMACY DATA FROM IADB.NL
    Visser, S. T.
    Vegter, S.
    Boersma, C.
    De Grooth, R.
    Postma, M. J.
    VALUE IN HEALTH, 2010, 13 (07) : A285 - A285
  • [50] Glycemic Outcomes Following Initiation of Insulin Glargine or Detemir at 1 Year
    Blonde, Lawrence
    Vaur, Laurent
    Levin, Philip
    Kendall, David M.
    DIABETES, 2009, 58 : A137 - A137
12345